Board of Directors

 

Richard R. Allen, CPA

Director

Co-founder of Regeneration Technologies, Inc. (Nasdaq:RTIX) in 1998, Mr. Allen developed the initial RTIX business plans and helped to negotiate the successful spin-off of the underlying RTIX technology from the University of Florida. As CFO of RTIX he negotiated the initial venture capital investments for the company and led the company's successful IPO in August 2000, raising $75 million. During his tenure as CFO he was responsible for finance, business development, IT, intellectual property and human resources. Mr. Allen has 28 years of experience in business and finance, including 16 years in executive leadership positions with technology-based businesses in the fields of engineering, electronics manufacturing, biomedical technology and medical device manufacturing. He is also licensed as a certified public accountant in the state of Florida.

Laurence Brody, DMD

Director

Laurence B. Brody, DDS has over 25 years of experience as an entrepreneur and senior executive, principally in the healthcare field.  From 1996 to 2009, Dr. Brody served as President and CEO of ConsoliDent, Inc. based in South Florida. Dr. Brody formed and developed ConsoliDent, Inc., a dental information management company, to acquire the assets and manage the financial business activities of dental offices.  In 1995, Dr. Brody served as President and CEO of MIDA Dental Plans, and was responsible for its sale in December 1995 to United Concordia.  From September 1994 to March 1995, Dr. Brody served as a consultant to AESGEN, a start-up generic pharmaceutical venture created by Mayo Medical Ventures, a unit of the Mayo Clinic and Applied Analytical Industries, a pharmaceutical development company. Dr. Brody serves on the Board of Overseers at the University of Pennsylvania School of Dental Medicine, and is an Associate Professor of the University of Pennsylvania School of Dental Medicine and Nova Southeastern College of Dental Medicine.  Dr. Brody has served as an advisor to the insurance departments in Florida, New Jersey, Maryland, Delaware and Pennsylvania..

Clifford Findeiss, MD

Director

Dr. Findeiss has an extensive background in the healthcare industry as an executive and entrepreneur. He was co-founder and CEO of both EMSA, Inc and its successor, InPhyNet Medical Management, Inc. from 1974 to 1997. The companies provided physician and healthcare personnel staffing and management services in over 30 states. InPhyNet’s clients included hospital emergency, radiology and anesthesiology departments, as well as prisons and jails, HMOs and U.S. Defense Department Hospitals. InPhyNet (IMMI: NASDAQ) grew to be a $450 million revenue company. The company was publicly traded from 1994 to 1997 when it was sold to Med-Partners, Inc.  Dr. Findeiss graduated from Northwestern University with a B.S. in Mechanical Engineering, 1964; an MD degree, 1968; and MS, Pharmacology in 1968. After post-graduate training at Jackson Memorial Hospital, he served in the US Navy, before returning to the University of Miami.  Dr. Findeiss was certified by the American Board of Emergency Medicine and practiced emergency medicine at several south Florida hospitals.  He served as President of the Florida College of Emergency Physicians and is a member of the Board of Directors of the Florida Emergency Medicine Foundation.

James LaBate

Director

Jim LaBate is a seasoned financial advisor and investment manager with over 24 years of experience. He is currently a Senior Vice President with a large investment bank, responsible for managing a large and diversified portfolio of assets for both wealthy individuals and institutional clients. Jim is a recipient of a Certificate in Investment Management Consulting (CIMC) and holds several insurance, real estate and securities industry licenses. Jim has been an active sponsor and investor in venture capital and private equity transactions, including corporate and real estate transactions, primarily in south and central Florida. He has served as a board member on several investment portfolio companies, including: Muvico Entertainment, Safari Internet, Swantech and Mobius Security Group. Jim has written numerous articles on financing and asset management, appeared on TV and radio and has been selected as a Top Financial Advisors by the South Florida Business Journal. He is a graduate of Indiana University of Pennsylvania with a BS in Business Administration and concentration in Accounting. He also attended graduate courses at Geneva College, FAU, and the University of Pittsburgh. Active in the community, he has chaired several fund raising projects for charities including the Boys and Girls Clubs, Community Foundation of Broward, and Broward College. He is a past Chairman of the Association of Corporate Growth and Broward College Foundation. He is a past Board member of the Coral Ridge Yacht Club, Nova’s Oceanographic School, Fort Lauderdale Parks and Recreation, YMCA, and the Executive’s Association of Fort Lauderdale. He also founded Fort Lauderdale Select, the City of Fort Lauderdale’s first travel soccer club. He is currently a Board member of the Boys and Girls Clubs and is a Leadership Broward Alumni.

Gonzalo Marquez

Director

Gonzalo is the managing partner of Falcon Opportunity Partners a private investment firm that provides capital to companies with significant growth prospects, compelling strategic positions and clear paths to profitability. Gonzalo was previously a Principal with Bank of America Equity Partners - Latin America, a $250 million private equity fund. Over a seven-year period, Gonzalo participated in the acquisition and sale of companies in the IT, telecom, entertainment, retail and food sectors. He led due diligence activities, structured transactions, and participated as a board member to portfolio companies. As a part of his responsibilities, Gonzalo managed investments in the U.S., Mexico, Brazil, Argentina and Venezuela. Gonzalo began his career working as a financial analyst with Continental Illinois Bank, where he participated in structuring debt financings for domestic middle market leveraged buyouts. Gonzalo received his BBA with High Distinction from the University of Michigan Business School.

Mead M. McCabe, Jr., MBA

President, Chief Financial Officer and Director

Mead has over 15 years experience in finance, start-up and technology oriented companies and is a management consultant in finance, business development and capital formation. In 1993 he joined Genetic Vectors and became CEO and CFO of the company which was a genomics company in Miami, Florida. He authored the company's strategic business plans, developing the strategy to spin the company out from its parent company through an IPO. In addition, he served as a founding board of directors member of BioFlorida and is a current member of the state's biotechnology trade organization. Prior to Genetic Vectors, Mr. McCabe was with Merrill Lynch as a financial consultant. He has a dual MBA in International Business and Finance from the University of Miami, Florida.

Jack B. Wilkens, MBA

Chairman and CEO

Jack has over 35 years of executive management experience. He is the former Chief Operating Officer and Executive Vice President of Consumer Diagnostics for Inverness Medical Innovations, Inc., (IMI) Waltham, Massachusetts. IMI is the leading point of care rapid diagnostic company worldwide with sales over $400 million and is the world's leading company in women's health diagnostics. Prior to the COO role, Jack was the Managing Director of Unipath, a wholly owned subsidiary of IMI, Inc. located in Bedford, England. During this period he led the expansion of sales in Women's Health diagnostics from $100 to $170 MM/year and led the launch of the IMI's digital pregnancy test the world's first consumer digital diagnostic test. From 2001 until 2003 he was Managing Director of IMI's and Johnson & Johnson's diabetes operations in Inverness, Scotland and responsible for IMI's European sales. The Scotland operation developed, manufactured and launched the world's leading blood glucose monitor. Sales expanded from zero to over 3 billion test strips sold today. Jack was VP of Medical Imaging Systems with Sterling Diagnostics/AGFA a $275 million per year business including the launch of three digital printing platforms. He also worked for Polaroid Corporation for many years in digital medical imaging, manufacturing, product development and marketing. He was responsible for the design, building and operation of Polaroid's digital imaging facilities, a $175 million investment and was involved in the conception, development and marketing of many instant imaging business systems. Jack has a BS in Chemical Engineering from Michigan State University and an MBA from Western New England College.